Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BAF357 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal VEGFR2/KDR/Flk-1 Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects human VEGFR2/KDR/Flk-1 in ELISAs and Western blots. In sandwich immunoassays, less than 0.5% cross-reactivity with recombinant mouse VEGFR2 is observed and less than 0.2% cross-reactivity with recombinant human (rh) VEGFR3 and rhVEGFR1 is observed.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Biotin
- Isotype
- IgG
- Vial size
- 50 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine.
Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants.
Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.
Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer.
PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis.
Morera Y, Sánchez J, Bequet-Romero M, Selman-Housein KH, de la Torre A, Hernández-Bernal F, Martín Y, Garabito A, Piñero J, Bermúdez C, de la Torre J, Ayala M, Gavilondo JV
Vaccine 2017 Jun 16;35(28):3582-3590
Vaccine 2017 Jun 16;35(28):3582-3590
Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants.
Sánchez Ramírez J, Morera Díaz Y, Bequet-Romero M, Hernández-Bernal F, Selman-Housein Bernal KH, de la Torre Santos A, Santiesteban Álvarez ER, Martín Bauta Y, Bermúdez Badell CH, de la Torre Pupo J, Gavilondo JV, CENTAURO-2 Team of Investigators, Ayala Avila M
BMC immunology 2017 Jul 26;18(1):39
BMC immunology 2017 Jul 26;18(1):39
Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.
Pfister C, Pfrommer H, Tatagiba MS, Roser F
British journal of cancer 2012 Nov 6;107(10):1702-13
British journal of cancer 2012 Nov 6;107(10):1702-13
Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer.
Fürstenberger G, von Moos R, Lucas R, Thürlimann B, Senn HJ, Hamacher J, Boneberg EM
British journal of cancer 2006 Feb 27;94(4):524-31
British journal of cancer 2006 Feb 27;94(4):524-31
PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis.
Eichler W, Yafai Y, Keller T, Wiedemann P, Reichenbach A
Experimental cell research 2004 Sep 10;299(1):68-78
Experimental cell research 2004 Sep 10;299(1):68-78
No comments: Submit comment
No validations: Submit validation data